Orkla India Q1 FY27 Results (NSE: ORKLAINDIA)
Signal: Growth reaccelerated
The read
The trajectory improved materially: revenue reached ₹659.1 crore, up 10.4% YoY after eight quarters without double-digit growth, with product sales up 11.5% versus 1.7% volume growth and both Spices at ₹436 crore, up 11.3%, and Convenience Foods at ₹220 crore, up 11.9%, contributing; the key monitor is whether the reported 19.7% EBITDA margin is sustained as growth broadens.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹659.1 Cr | 10.4% | N/A |
| EBIT | ₹117.46 Cr | N/A | |
| Net profit | ₹87.71 Cr | 9.7% | |
| EPS | ₹6.4 | 11.1% | |
| EBIT margin | 19.7% |
P&L walk
Revenue increased to ₹659.1 crore, up 10.4% YoY and supported by 11.5% product-sales growth versus 1.7% volume growth; EBITDA was ₹129.89 crore at a 19.7% margin, while PAT reached ₹87.71 crore with the filing reporting 9.7% growth before exceptional items.
Key positives
- Revenue reached ₹659.1 crore, up 10.4% YoY, marking a return to double-digit growth after eight quarters.
- Product sales grew 11.5% YoY versus 1.7% volume growth, indicating meaningful support from realisation, mix and/or operating revenue.
- Digital commerce grew 38.1% YoY and increased to 8.9% of domestic revenue from 7.2% in Q1FY26.
- GCC revenue grew 18.1% YoY, providing a faster-growing international engine within the 10.1% international-business growth.
- Spices and Convenience Foods grew 11.3% and 11.9% respectively, showing broad-based category momentum rather than reliance on one disclosed category.
- The 19.7% consolidated EBITDA margin and EPS growth of 11.1% indicate that earnings kept pace with the revenue recovery.
Key concerns
- Volume growth was only 1.7% YoY against 11.5% product-sales growth, making sustained volume acceleration important for the durability of the revenue trajectory.
- The filing's press-release EBITDA of ₹115 crore at a 17.5% margin differs from the authoritative XBRL EBITDA of ₹129.89 crore at a 19.7% margin; the definition and reconciliation should be monitored for comparability.
Research and educational content only. Not investment advice.